Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Growing Impatient With Lack of Disclosure, Repeats Demands

Page 11 of 14

Page 11 of 14 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: June 2, 2016

Wildcat Capital Management, LLC

By:   /s/ Leonard A. Potter   

Name:  Leonard
A. Potter
Title: President 

 

Wildcat – Liquid Alpha, LLC

By:   /s/ Clive Bode           
Name:  Clive Bode
Title: President

Infinity Q Capital Management, LLC

By:   /s/ Leonard A. Potter   

Name:  Leonard
A. Potter
Title: Chief Executive Officer 

 

Infinity Q Management Equity, LLC

By:   /s/ James Velissaris           
Name: James Velissaris
Title: Sole Manager

Infinity Q Diversified Alpha Fund

By: Infinity Q Capital Management, LLC

By:   /s/ Leonard A. Potter   
Name:  Leonard A. Potter
Title: Chief Executive Officer

Page 11 of 14 Pages

Follow Sorrento Therapeutics Inc. (NASDAQ:SRNEQ)

Page 11 of 14